LEWIS JOEL sold 0.9% of their position (7.83K shares) of GALECTIN THERAPEUTICS INC on the open market
Open‑market sale worth $55.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/19/2025ACC: 0001133416-25-000071
-7.83K
Net shares
Net seller
$55.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7.83K acquired · 15.66K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.83K
Price / share
$2.86
Trade value
$22.39K
% of position
0.9%
12/17/2025
832.59K→840.42K
Common Stock
Direct
Shares
−7.83K
Price / share
$7.06
Trade value
$55.24K
% of position
0.9%
12/17/2025
840.42K→832.59K
Total
Net shares
+0.00
Net value
-$32.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/17/2025 | M · Option Exercise | +7.83K | $2.86 | $22.39K | 0.9% | 832.59K | 840.42K |
| Common Stock Direct | 12/17/2025 | S · Sale | −7.83K | $7.06 | $55.24K | 0.9% | 840.42K | 832.59K |
| Total | +0.00 | -$32.85K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
7.83K shares
Shares
−7.83K
Strike price
2.86
Held after
32.17K
Exercisable
—
12/17/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock7.83K shares | 12/17/2025 | M · Option Exercise | −7.83K | 2.86 | — | 32.17K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2K
Total
2K indirect2K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2K | Indirect |
| Total | 2K | 2K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported